11.31
price down icon2.79%   -0.325
 
loading

Daxor Corporation Borsa (DXR) Ultime notizie

pulisher
Mar 04, 2026

DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com

Mar 04, 2026
pulisher
Mar 03, 2026

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget

Mar 03, 2026
pulisher
Mar 03, 2026

Daxor reports 45% revenue growth, plans regulatory shift - Investing.com

Mar 03, 2026
pulisher
Mar 03, 2026

Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Daxor (DXR) Records Strong Growth and Regulatory Changes in 2025 - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

Daxor issues update in Letter to Shareholders - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Daxor (DXR) Secures FDA Clearance for Advanced Blood Volume Anal - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

FDA clears faster blood volume test as Daxor revenue surges 45% - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

DXR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 02, 2026
pulisher
Mar 02, 2026

FDA‑cleared BVA boosts momentum; Daxor (NASDAQ: DXR) posts NAV $9.07 and $46M operating valuation - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 02, 2026
pulisher
Feb 28, 2026

Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0% - MarketBeat

Feb 28, 2026
pulisher
Feb 27, 2026

Daxor Corporation (DXR) Competitors - Meyka

Feb 27, 2026
pulisher
Feb 27, 2026

Daxor (NASDAQ:DXR) vs. Addus HomeCare (NASDAQ:ADUS) Financial Survey - Defense World

Feb 27, 2026
pulisher
Feb 27, 2026

EBIT per share of Daxor Corporation – NASDAQ:DXR - TradingView

Feb 27, 2026
pulisher
Feb 26, 2026

Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Feb 26, 2026
pulisher
Feb 25, 2026

Daxor continues strategic expansion, opens new BVA program in Tennessee - TipRanks

Feb 25, 2026
pulisher
Feb 24, 2026

Daxor (DXR) Expands BVA Program to Southern Middle Tennessee - GuruFocus

Feb 24, 2026
pulisher
Feb 24, 2026

Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee - The Manila Times

Feb 24, 2026
pulisher
Feb 20, 2026

Gainers Report: Will LightPath Technologies Inc benefit from government policy2025 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 18, 2026

Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Feb 18, 2026
pulisher
Feb 14, 2026

Is Daxor Corporation stock a safe haven assetWeekly Profit Summary & Stock Portfolio Risk Control - mfd.ru

Feb 14, 2026
pulisher
Feb 12, 2026

Can Daxor Corporation stock double in next 5 yearsTrade Risk Report & Fast Entry and Exit Trade Plans - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Daxor to shift regulatory reporting from Investment Company Act By Investing.com - Investing.com South Africa

Feb 11, 2026
pulisher
Feb 10, 2026

Winners Losers: Is Daxor Corporation a turnaround storyWeekly Earnings Recap & Reliable Price Breakout Alerts - baoquankhu1.vn

Feb 10, 2026
pulisher
Feb 10, 2026

Daxor Corp reaffirms focus on blood volume analysis technology - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology - TradingView

Feb 10, 2026
pulisher
Feb 10, 2026

Daxor to transition to Securities Exchange Act of 1934 reporting company - TipRanks

Feb 10, 2026
pulisher
Feb 10, 2026

Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business - The Manila Times

Feb 10, 2026
pulisher
Feb 10, 2026

Daxor Corporation Announces Transition To Securities - GlobeNewswire

Feb 10, 2026
pulisher
Feb 10, 2026

Daxor (NYSEAMERICAN:DXR) Stock Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat

Feb 10, 2026
pulisher
Feb 07, 2026

Trading the Move, Not the Narrative: (DXR) Edition - Stock Traders Daily

Feb 07, 2026
pulisher
Feb 05, 2026

Daxor (NASDAQ:DXR) Stock Price Up 0.6%Time to Buy? - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Contrasting Daxor (NASDAQ:DXR) and Quest Diagnostics (NYSE:DGX) - Defense World

Feb 05, 2026
pulisher
Feb 03, 2026

Aug Swings: Should I invest in Daxor Corporation before earningsPortfolio Profit Report & Safe Entry Point Alerts - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 01, 2026

Guidance Update: Is Daxor Corporation a turnaround storySwing Trade & Stock Timing and Entry Methods - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 29, 2026

What is the PEG ratio of Daxor CorporationOil Prices & Safe Entry Momentum Stock Tips - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

What are Daxor Corporation’s technical support levels2025 Growth vs Value & Accurate Intraday Trading Signals - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Aug Outlook: Will Daxor Corporation stock go up in YEAR2025 Buyback Activity & Real-Time Buy Zone Alerts - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 27, 2026

Daxor completes $8.1 million direct offering of common stock on Nasdaq - Investing.com Australia

Jan 27, 2026
pulisher
Jan 26, 2026

Daxor Signs Multiple Material Agreements - TradingView

Jan 26, 2026
pulisher
Jan 24, 2026

Daxor Corporation Announces $9 Million Registered Direct Offering - Sahm

Jan 24, 2026
pulisher
Jan 24, 2026

Daxor Releases Updated Investor Presentation to Public Markets - The Globe and Mail

Jan 24, 2026
pulisher
Jan 23, 2026

Daxor prices 765,958 shares at $11.75 in registered direct offering - TipRanks

Jan 23, 2026
pulisher
Jan 23, 2026

Daxor to raise $9M in new stock sale at $11.75 a share - Stock Titan

Jan 23, 2026
pulisher
Jan 18, 2026

Why is Daxor Corporation stock going downAnalyst Downgrade & Capital Efficiency Focused Ideas - bollywoodhelpline.com

Jan 18, 2026
pulisher
Jan 16, 2026

Price-Driven Insight from (DXR) for Rule-Based Strategy - Stock Traders Daily

Jan 16, 2026
pulisher
Jan 14, 2026

Daxor Corporation (NASDAQ:DXR) Sees Large Increase in Short Interest - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

RSI Check: Is SANA stock a buy or sellNew Guidance & High Accuracy Swing Entry Alerts - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 13, 2026

Market Leaders: Should I hold or sell Daxor Corporation stock in 2025Portfolio Performance Report & Consistent Profit Trade Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 12, 2026

Aug Macro: What are the analyst revisions for FACTWIs Daxor Corporation stock a good investment in YEARWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 11, 2026

Risk Recap: Will Daxor Corporation stock maintain momentum in 20252025 Earnings Impact & Daily Profit Focused Stock Screening - Bộ Nội Vụ

Jan 11, 2026
pulisher
Jan 09, 2026

CHL Limited Bounces Off Moving Average SupportChart Pattern Recognition & Maximum Capital Growth - bollywoodhelpline.com

Jan 09, 2026
pulisher
Jan 08, 2026

How Greenlane Holdings Inc. stock reacts to Fed rate cutsQuarterly Performance Summary & Consistent Profit Trade Alerts - Улправда

Jan 08, 2026
$70.14
price down icon 0.40%
$176.83
price down icon 2.65%
medical_instruments_supplies COO
$80.60
price down icon 1.73%
$75.53
price down icon 0.16%
medical_instruments_supplies WST
$244.20
price down icon 1.92%
$43.14
price up icon 0.58%
Capitalizzazione:     |  Volume (24 ore):